Browsed by
Tag: HIV

Beyond Investment in Research: What COVID-19 Policymakers Can Learn from the HIV/AIDS Epidemic

Beyond Investment in Research: What COVID-19 Policymakers Can Learn from the HIV/AIDS Epidemic

Widespread investment in biomedical research has made many Americans tentatively optimistic about the resolution of the COVID-19 pandemic. In the public sector, the Coronavirus Aid, Relief, and Economic Security (CARES) Act has provided nearly $10 billion in funding for therapy and vaccine development through agencies like the NIH and CDC. This effort has culminated in two important milestones: the discovery that remdesivir, a drug developed to treat Ebola, reduces morbidity for patients hospitalized with severe COVID-19, and the introduction of…

Read More Read More

Data Control and Surveillance in the COVID-19 Response

Data Control and Surveillance in the COVID-19 Response

In a paper published last month, we argue that the emerging emphasis on digital technologies in the global tuberculosis (TB) response is ushering in a new era of data colonization and surveillance in the name of public health. We assert that, despite some promise, digital adherence technologies for TB create copious amounts of data that threaten to infringe human rights, ultimately hindering the disease response. The elephant in the room (or in the paper), of course, is the coronavirus outbreak…

Read More Read More